Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Cash & Current Investments (2010 - 2026)

Geron's (GERN) quarterly Cash & Current Investments came in at $300.8 million in Q2 2026, down 22.46% year-over-year from $388.0 million in Q2 2025, and down 3.7% quarter-over-quarter from $312.4 million in Q1 2026.

Analysis

Geron (GERN) Cash & Current Investments (2010 - 2026) Analysis & Trends

Geron has disclosed Cash & Current Investments across 17 years of filings, most recently posting $300.8 million for Q2 2026.

  • In Q2 2026, Cash & Current Investments fell 22.46% year-over-year to $300.8 million; the TTM figure through Jun 2026 stood at $300.8 million (down 22.46% YoY), while the FY2025 annual figure was $357.9 million, down 11.97% from the prior year.
  • Cash & Current Investments came in at $300.8 million for Q2 2026 at Geron, down from $312.4 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $443.0 million in Q1 2024 to a low of $166.7 million in Q1 2022.
  • Average Cash & Current Investments over 5 years is $324.5 million, with a median of $348.8 million recorded in 2024.
  • Year-over-year, Cash & Current Investments jumped 128.44% in 2023 and slipped 22.46% in 2026.
  • Over 5 years, Cash & Current Investments stood at $172.7 million in 2022, then jumped by 93.17% to $333.7 million in 2023, then grew by 21.84% to $406.6 million in 2024, then retreated by 11.97% to $357.9 million in 2025, then slipped by 15.94% to $300.8 million in 2026.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $300.8 million in Q2 2026, $312.4 million in Q1 2026, and $357.9 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 13.99 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 3.18 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 7.85 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 7.99 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 5.18 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.14 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 3.31 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 1.29 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Geron 914.60 Mn 613.75 Mn - 300.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 300.85 Mn
Mar 31, 2026 312.40 Mn
Dec 31, 2025 357.92 Mn
Sep 30, 2025 380.53 Mn
Jun 30, 2025 387.98 Mn
Mar 31, 2025 396.88 Mn
Dec 31, 2024 406.57 Mn
Sep 30, 2024 339.77 Mn
Jun 30, 2024 362.73 Mn
Mar 31, 2024 443.05 Mn
Dec 31, 2023 333.70 Mn
Sep 30, 2023 313.53 Mn
Jun 30, 2023 371.38 Mn
Mar 31, 2023 380.74 Mn
Dec 31, 2022 172.75 Mn
Sep 30, 2022 194.79 Mn
Jun 30, 2022 219.29 Mn
Mar 31, 2022 166.67 Mn
Dec 31, 2021 183.72 Mn
Sep 30, 2021 176.12 Mn